Proteomic analysis of HEK293 cells expressing non small cell lung carcinoma ...
In view of the fact that certain non small cell lung carcinoma associated epidermal growth factor receptor mutations keep the receptor constitutively active, the downstream effectors of altered activity of mutant receptors are largely unknown. By 2D ...
7thSpace Interactive (press release) - Thu, 11 Jun 2015 12:07

Heat-shock factor 2 is a suppressor of prostate cancer invasion
Intriguingly, low levels of HSF2 mRNA were detected in many types of malignancies (Figure 9a), including other epithelial cancers, for example, invasive breast carcinoma, small-cell lung carcinoma and ovarian serous papillary carcinoma (Figures 9a and ...
Nature.com - Mon, 29 Jun 2015 02:56

Comorbidities increase risk for lung cancer mortality
Male sex, as well as small cell, large cell and other cell carcinomas vs. adenocarcinoma were associated with a more advanced-stage diagnosis of lung cancer, whereas squamous cell carcinoma was associated with earlier-stage diagnoses compared with ...
Healio - Fri, 26 Jun 2015 15:07

Pre-Market News Alert on: Splunk (NASDAQ:SPLK), Pattern Energy Group ...
Its lead oncology drug candidate comprises ganetespib, an Hsp90 inhibitor, which is in Phase III clinical trial for the treatment of non-small cell lung cancer; in Phase II clinical trial for patients with hormone receptor positive metastatic breast ...
wsnewspublishers - Mon, 29 Jun 2015 03:23

People With Thyroid Cancer in The Nordic Region Now Able to Benefit From ...
Lenvatinib is indicated for the treatment of adult patients with progressive locally advanced or metastatic, differentiated (papillary, follicular, Hürthle cell) thyroid carcinoma (DTC) refractory to radioactive iodine (RAI). Lenvatinib shows a ...
Virtual Press Office (press release) - Sun, 28 Jun 2015 16:03



3rd new clinical trial combines immunotherapy with chemotherapy
Recent data reported in the New England Journal of Medicine(1),(2) and Lancet(3) demonstrates promising results with antibody-based immunostimulatory therapy in treating melanoma, renal cell carcinoma, non-small cell lung cancer and colorectal cancer.
Pharmaceutical Processing - Fri, 26 Jun 2015 10:26



Latest Findings on Vitamin D and Cancer Link
In the other study presented at Clinical Nutrition Week, 270 patients with newly diagnosed stage III/IV non-small cell lung cancer (NSCLC) underwent a vitamin D evaluation before receiving any treatment between January 2008 and December 2010 (poster ...
General Surgery News - Mon, 29 Jun 2015 13:48

KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated ...
KRAS mutations are limited to non-small-cell lung cancer, which is the most prevalent form of lung cancer. The K-ras protein belongs to a small GTP-binding protein family, which acquires transforming activity with specific mutations, such as a mutation ...
Nature.com - Fri, 26 Jun 2015 05:02


<-   1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014